Analysts Remain Bullish on AtaiBeckley Inc. Despite Recent Merger

viernes, 30 de enero de 2026, 8:31 pm ET1 min de lectura
ATAI--

H.C. Wainwright maintains a Buy rating on AtaiBeckley Inc. (ATAI) with a $15 price target, citing the company's leadership in next-generation psychiatry and the potential for rapid clinical adoption of its lead asset, BPL-003. Guggenheim also initiated a Buy rating with an $11 price target, while JonesTrading maintained a Buy rating with a $16 price target.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios